Metformin+Sitagliptin
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients (NCT05167513) | Getz Pharma | 2021-01-01 |
Track Metformin+Sitagliptin automatically
Every clearance here is in the API, with alerts when new ones post.